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The effect of aqueous extract of Spondias mombin leaves extract on lipid peroxidation and antioxidant 
activity in alloxan induced diabetes was studied. Forty male albino Wistar rats (100-150 g body weight) were 
used. The rats were randomly selected into four groups containing 10 rats each. Group 1 was the control group 
and it was placed on normal rat chow. Group 2 was the Spondias mombin (spm) group placed on normal rat 
chow and given 250 mg/kg extract orally. Group 3 was the alloxan-induced diabetic (150 mg/kg) group (DM) 
and Group 4 was the diabetic group treated with 250 mg/kg extracts (Dm+spm). At the end of 30 days blood 
samples were collected by cardiac puncture and used for biochemical analysis. Results obtained revealed that 
blood glucose level in group 3 (Dm) was significantly higher (p<0.05) than control but the administration of 
Spondias mombin leaves extract significantly reduced the blood glucose level (p<0.05). Total cholesterol (TC), 
triglycerides (TG) and Low Density Lipoprotein (LDL) were significantly raised in the diabetic group while 
High Density Lipoprotein (HDL) was significantly reduced (p<0.05). Treatment with extract decreased TC, 
TG, LDL but significantly increased the HDL level (p<0.05). Lipid peroxidation was increased in the diabetic 
group and treatment with extract significantly reduced (p<0.05) the level of lipid peroxidation. Superoxide 
dismutase (SOD) and catalase (CAT) activities were decreased significantly in the diabetic group. 
Administration of extracts increased the antioxidant enzymes activities.  The result suggests that aqueous 
extracts of Spondias mombin leaves possess hypoglycemic effects and improve lipid profile of diabetic rats. 
This effect may be secondary to its ability to reduce oxidative stress. 
© 2016 International Formulae Group. All rights reserved. 
 




Most plants in every part of Africa are 
used for the treatment of different kinds of 
ailment and diseases. Spondias mombin is 
among the notable plants that play vital role in 
the management of various disease conditions. 
These conditions include cardiovascular 
diseases, dysentery, heamorrhoids, and 
diarrhea (Martinez, 2000). The plant leaves 
have been reported to contain antiviral 
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ellagtannins, caffenyl esters and phenolic 
acids (Corthout et al., 1994).  
 In traditional medicine, the extracts of 
fresh boiled leaf of Spondias mombin have 
been reported to be used in the treatment of 
dizziness, and are said to be strongly 
abortificient (Offiah and Anyanwu, 1989). 
Among the Phytochemical components of the 
leaves of Spondias mombin are alkaloids, 
flavanoids, tannins, saponins and phenolic 
compounds (Nnjoku and Akumefula, 2007). 
Flavanoids as antioxidant, they scavenge free 
radicals and prevents oxidative cell damage 
and also provides anticancer activity. Other 
basic function of the flavanoids includes its 
ability to protect against allergies, 
inflammation, platelet aggregation and ulcer 
(Okolie et al., 2008). According to Iweala et 
al. (2011), the seed of Spondia mombin 
possess hypoglycemic effects in alloxan 
induced diabetic rats. However nothing is 
known about the hypoglycemic effect of the 
leave extract of Spondia mombin in diabetic 
rats. Diabetes mellitus is a disease associated 
with defect in glucose metabolism (WHO, 
1999) and is linked to oxidative stress induced 
by hyperglycemia (Iwaela et al., 2000) which 
manifest into hyperlipidemia and 
hypercholesterolaemia (Ross, 1999). It is 
estimated that about 3.2 million people died of 
diabetes related conditions annually. This 
situation is worst in developing countries 
where the number of people affected is 
expected to increase by 150% by 2030 (Hope, 
2004). Management of diabetes mellitus 
usually involves adjustment of the patient 
lifestyle or in some cases supplementary with 
agents that lower blood sugar level.  Recently 
attentions have been shifted toward the use of 
medicinal plant in the management of 
degenerative diseases such as diabetes 
mellitus.  Therefore this study is designed to 
investigate the effects of aqueous leave extract 
of Spondias mombin on hypolipidemic, 
hypoglycemic and level of oxidative stress 
caused by alloxan-induced diabetes mellitus in 
Wistar rats. 
              
MATERIALS AND METHODS 
Preparation of leaf extract of Spondias 
mombin 
The fresh leaves of Spondias mombin 
were collected, washed and dried in the 
laboratory for two weeks and the leaves 
ground to powder. The powdered Spondias 
mombin leaves were extracted by the bulk 
using the soxhlet extraction method. The 
liquid extract obtained was slowly evaporated 
in vacuo. The total yield was 28.06 g. The 
extract was used to prepare the required test 
concentrations. The extract was stored in the 
refrigerator at 4 oC. 
 
Experimental design 
Forty male albino Wistar rats weighing 
100-150g were obtained from the Animal 
House of Department of Physiology, Cross 
River University of Technology, Okuku 
Campus, Nigeria. Four groups containing 10 
rats each were randomly selected and used for 
the study. All the animals had access to feed 
and water ad libitum. Group 1 was the control 
(cont), fed on normal feed. Group two was the 
Spondias mombin (SPM) group fed on normal 
feed and administered with 250 mg/kg of 
extract. Group 3 was the alloxan induced (150 
mg/kg) diabetic group untreated (DMU) and 
group 4 was the diabetic group treated with 
the extract (250 mg/kg). Diabetes was induced 
by intraperitoneal injection of 150 mg/kg 
bolus of alloxan. Accu check glucometer was 
used to confirm them diabetic after 3 days. At 
the end of 28 days, the animals were fasted for 
12 hours, anesthetized with ether and blood 
samples collected via cardiac puncture and put 
into EDTA blood sample bottles for 
biochemical analysis. 
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Measurement of biochemical parameters 
Blood samples were collected by 
cardiac puncture, put in EDTA sample bottle. 
Glucose oxidase method of Trinder (1969) 
was used for glucose determination.  
To determine total cholesterol level in 
blood, Siedel et al. (1983) method was used. 
Enzymatic cholesterol colorimetric kit was 
used for analysis and absorbance measured at 
550 nm against the reagent blank. Triglyceride 
was determined by the method of Sullevian et 
al. (1985). The equation of Friedwald et al. 
(1972) (LDL =TC-HDL+ TG/2.23) was used 
to estimate LDL-c level. 
Protein was determined according to 
the method of Lowry et al. (1951) using 
standard protein solution. The method of 
Buege and Aust (1978) was used to determine 
lipid peroxidation. The levels of total 
superoxides dismutase was determined by the 
method of Misra and Fridovich (1972) while 
catalase activity was determine according to 
the method of Sinha (1971). 
 
Data analysis 
All data are presented as the means ± 
Standard Error of Mean (SEM). One way 
analysis of variance (ANOVA) was used for 
the analysis followed by a post-hoc Turkey’s 
HSD test using the SPSS software package 
version 13.0. Means was considered to be 
significant at p< 0.05. 
 
RESULTS 
Blood glucose  
As shown in Figure 1, blood glucose 
level was significantly (p<0.05) increased in 
alloxan-induced diabetic rats (115.86 ± 5.0 
mg/dl) when compared with control (84.57 ± 
3.0 mg/dl). 
Following the oral administration of 
extract, blood glucose level decreased 
significantly (p<0.05) to 90.0 ± 2.0 in the 




The TC in the diabetic untreated was 
significantly increased (p˂0.05) when 
compared with the diabetic treated (Table 1). 
The mean triglyceride (mg/dl) in diabetic 
group was significantly (p˂0.01) elevated 
compared with the control. Administration of 
extract to the diabetic group lowered the TC 
level significantly (p˂0.01) by about 19.6%. 
The mean level of low density 
lipoprotein (LDL-c) in the diabetic group was 
significantly (p˂0.05) raised but lowered 
remarkably (70.8% and 26.36% respectively) 
following the administration of the extract. 
The high density lipoprotein cholesterol level 
(HDL-c) significantly (p˂0.05) decreased in 
the diabetics when compared to control (Table 
2).  
 
Tissue lipid peroxidation and antioxidant 
enzyme 
At the end of 28 days administration of 
extract, there was significant (p<0.05) 
increase in lipid peroxidation in the diabetic 
group compared to the control. Lipid 
peroxidation was significantly reduced in the 
diabetic treated and Spondias mombin group 
only (Figure 2). 
Superoxide dismutase (SOD) activity 
was significantly (p<0.05) reduced in the 
diabetics compared to the control. There was a 
significant increase in SOD activity in both 
Spondias mombin group and the diabetics 
treated group (47.52%) when compared to the 
diabetic untreated group (Table 1).  
Catalase activity was also significantly 
(p<0.05) lowered in the diabetic group 
compared to the control. In the Spondias 
mombin and diabetics treated groups, catalase 
activity was significantly (p<0.05) increased 
(25%) (Table 1). 
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Table 1: Effect of aqueous extract of Spondias mombin leaves on lipid profile and antioxidant 
activity in alloxan induced diabetes mellitus. 
 
Parameters CONTROL SPM DMU DM+SPM 
TC (mg/dl) 153.4 ± 3.0 143.66 + 3.0 176.46 ± 2.0* 154.56 ± 3.0 
TG (mg/dl) 130.64 ± 4 118.09± 5.0 209.14 ± 15* 154.40 ± 13 
HDL (mg/dl) 101.97 ± 4 107.73±10 87.79 ± 3* 118.34±1.3 
LDL (mg/dl) 26.20± 8.0 21.57± 2.0 36.02± 2.0 10.49± 1.3 
SOD (mol/g/protein) 13.16 ±1.2 9.71 ± 0.7 5.43 ± 0.8* 10.96 ± 1.1 
Catalase (Kat f) 0.18±0.01 0.11 ± 0.02 0.06 ± 0.01* 0.10 ± 0.01 
*p<0.05 significant different from control 
SPM= Spondias mombin group, DM= Diabetic untreated group, DM+SPM (Diabetic treated with Spondias mombin) 
 
Table 2: Effect of aqueous extract of Spondias mombin leaves on HDL/LDL ratio in alloxan 
induced diabetes mellitus.  
 
PARAMETERS CONT. SM DM DM+SPM 
HDL mg/dl. 101.97 ± 4.0 107.73 ± 1.4 87.79 ± 3.0 118.34 ± 1.3 
LDL-c 26.20 ± 8.0 21.57 ± 2.0 36.02 ± 2.0 10.49 ± 1.0 
Ratio 3.9 : 1 5.0 : 1 2.4 : 1 11.3 : 1 
SPM= Spondias mombin group, DM= Diabetic untreated group, DM+SPM (Diabetic treated with Spondias mombin) 
 
 
Figure 2:  Fasting blood sugar following administration of Spondia mombin leave extract to 
diabetic rats. *p<0.05 significantly different from control. 




Figure 2:  Serum MDA following administration of Spondia mombin leave extract to diabetic rats. 
*p<0.05 significantly different from control. 
SPM= Spondias mombin group, DM= Diabetic untreated group, SPM/DM= Diabetic treated with Spondias mombin 




The aim of the present study was to 
evaluate the effect of the oral administration 
of the aqueous extract of Spondias mombin 
leaves on lipid peroxidation caused by 
alloxan-induced diabetes and its antioxidant 
activity. 
In this study, the results obtained 
showed that there was a significant decrease 
in blood glucose level and cholesterol level in 
the diabetic treated group suggesting an anti-
hyperglycemic and hypolipidemic activity of 
the Spondias mombin leaves extract. Diabetes 
mellitus is a condition in which the regulatory 
mechanism of blood glucose in the body is 
distorted. Hyperglycemia either in humans or 
experimented animals cause some level of 
metabolic insults resulting from radical 
damage to tissues following production of 
reactive oxygen species and depletion of 
antioxidant enzymes ( Soto et al., 2002). The 
blood glucose level reduction shown in this 
study both in the groups administered with 
Spondias mombin extract and the diabetes 
treated groups suggest that there may be an 
active component in this extract that promotes 
blood glucose suppression probably via 
pancreatic B-cell regeneration, or insulin 
sensitivity of tissues. This observation is in 
agreement with the report of Iwaela et al. 
(2011), that the seed extract of Spondias 
mombin possess hypoglycemic effects in 
alloxan induced diabetic rats.  
In this study, data presented shows that 
TG, LDL and VLDL-C levels were raised in 
the alloxan induced diabetic groups and also 
an increased TC level in the diabetic untreated 
group. Treatment with the leave extract 
significantly reduced the TC, TG, LDL and 
VLDL levels in the diabetics and normal rats. 
This result suggests that the leave extract may 
be having the component responsible for 
preventing the possible development of 
atherosclerotic plagues which forms a major 
risk factor in the development of high blood 
pressure (Wiebickia and Mikhailidis, 2002). 
The increase in HDL-c observed in this study 
is in variance with the earlier work by Ojiako 
and Nwanyo, 2006, who reported a decrease 
in HDL-C caused by the extract.   
Lipid peroxidation in the diabetic 
treated and Spondias mombin groups were 
significantly reduced while catalase and 
superoxide dismutase enzyme activity in these 
groups were increased. In diabetes, reports 
have shown that auto-oxidation occurs leading 
to increased peroxidation and release of free 
radicals such as superoxide anions and 
reactive oxygen species (Soto et al., 2002; 
Hink et al., 2000). This free oxidants evokes 
chain reaction leading to depletion of 
antioxidant enzymes like SOD, catalase and 
glutathione peroxidase  and cell damage 
(Cariello, 2006) Studies have shown that 
SOD, flavonoid and catalase are antioxidants 
that scavenges free radicals and prevent 
oxidative cell damage (Wu and Cederbaum., 
2003). From our result, the elevated SOD and 
catalase level and reduced peroxidation may 
therefore suggest that Spondias mombin leave 
extract elicit ROS scavenging and 
detoxification potentials as well as the 
capacity of preventing lipid peroxidation. 
 
Conclusion 
The result suggests that aqueous 
extracts of Spondias mombin leaves possess 
hypoglycemic effects and improve lipid 
profile of diabetic rats. This effect may be 
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